PBM files response to suit
This article was originally published in The Tan Sheet
Executive Summary
PBM Products filed a formal response to a law suit filed by Mead Johnson alleging trade dress infringement, false designation of origin and unfair competition related to the PBM-introduction of store-brand infant formula Member's Mark Infant Formula. The case, filed Jan. 4 in the U.S. District Court for Southern Indiana, contends Mead's Enfamil LIPIL product has suffered in sales due to similarity in packaging of Member's Mark. PBM denies all allegations. PBM CEO Paul B. Manning says the reason for Enfamil LIPIL's sales downturn is, "Moms and dads realize that, given the federal regulations that govern infant nutrition, price, and not brand, is what really matters when it comes to buying baby formula." A telephone conference to address settlement will be held April 13...
You may also be interested in...
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.